Clinical impact of BAALC expression in high-risk acute promyelocytic leukemia

Although overexpression of the brain and acute leukemia, cytoplasmic (BAALC) gene is associated with primary resistant disease and shorter relapse-free, disease-free, and overall survival in different subsets of acute myeloid leukemia (AML), little is known about its clinical impact in acute promyel...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Blood Adv
Main Authors: Lucena-Araujo, Antonio R., Pereira-Martins, Diego A., Koury, Luisa C., Franca-Neto, Pedro L., Coelho-Silva, Juan L., de Deus Wagatsuma, Virginia M., Melo, Raul A. M., Bittencourt, Rosane, Pagnano, Katia, Pasquini, Ricardo, Chiattone, Carlos S., Fagundes, Evandro M., Chauffaille, Maria de Lourdes, Schrier, Stanley L., Tallman, Martin S., Ribeiro, Raul C., Grimwade, David, Ganser, Arnold, Löwenberg, Bob, Lo-Coco, Francesco, Sanz, Miguel A., Berliner, Nancy, Rego, Eduardo M.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2017
Assuntos:
Myeloid Neoplasia
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5728094/
https://ncbi.nlm.nih.gov/pubmed/29296827
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2017005926
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados